New treatment strategy aims to stop rare liver cancer

An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.   Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...

Valuable recognition for OHSU’s molecular pathology fellowship

OHSU’s Molecular Genetic Pathology Fellowship has received a grant from NeoGenomics Laboratories that will support fellows for the 2021-22 and 2022-23 academic years in the Knight Cancer...

For veterans with prostate cancer, a new center of excellence in Oregon

VA Portland Health Care System and OHSU are launching a precision oncology center of excellence supported by the Prostate Cancer Foundation. On Veteran's Day, the foundation announced $5 million in...

Helping more bladder cancer patients preserve a functioning bladder

Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...

Shining a light on cancer care disparities

Image: NCI. . For some marginalized populations in the U.S., barriers preventing access to radiation therapy and other lifesaving cancer care are as insurmountable as those in the poorest nations,...

Halting resurgent prostate cancers before they spread

Q&A: Prostate cancer expert Julie Graff, M.D., explains how a new treatment option fills a void for men with resurgent tumors. When prostate cancer isn't cured by surgery or radiation, the...